Annual CFI
$153.66 M
+$64.54 M+72.42%
31 December 2023
Summary:
FibroGen annual cash flow from investing activities is currently $153.66 million, with the most recent change of +$64.54 million (+72.42%) on 31 December 2023. During the last 3 years, it has fallen by -$298.83 million (-66.04%). FGEN annual CFI is now -66.04% below its all-time high of $452.49 million, reached on 31 December 2020.FGEN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$755.00 K
-$71.48 M-98.95%
30 September 2024
Summary:
FibroGen quarterly cash flow from investing activities is currently $755.00 thousand, with the most recent change of -$71.48 million (-98.95%) on 30 September 2024. Over the past year, it has dropped by -$53.46 million (-98.61%). FGEN quarterly CFI is now -99.51% below its all-time high of $153.85 million, reached on 30 June 2020.FGEN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$134.51 M
-$53.46 M-28.44%
30 September 2024
Summary:
FibroGen TTM cash flow from investing activities is currently $134.51 million, with the most recent change of -$53.46 million (-28.44%) on 30 September 2024. Over the past year, it has dropped by -$10.00 million (-6.92%). FGEN TTM CFI is now -70.27% below its all-time high of $452.49 million, reached on 31 December 2020.FGEN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FGEN Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +72.4% | -98.6% | -6.9% |
| 3 y3 years | -66.0% | +100.6% | +157.8% |
| 5 y5 years | +129.4% | -99.5% | +142.3% |
FGEN Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -66.0% | +136.0% | -99.3% | +100.6% | -28.4% | +131.5% |
| 5 y | 5 years | -66.0% | +129.4% | -99.5% | +100.4% | -70.3% | +131.5% |
| alltime | all time | -66.0% | +129.4% | -99.5% | +100.2% | -70.3% | +123.8% |
FibroGen Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $755.00 K(-99.0%) | $134.51 M(-28.4%) |
| June 2024 | - | $72.24 M(+40.9%) | $187.97 M(+85.3%) |
| Mar 2024 | - | $51.28 M(+400.6%) | $101.45 M(-34.0%) |
| Dec 2023 | $153.66 M(+72.4%) | $10.24 M(-81.1%) | $153.66 M(+6.3%) |
| Sept 2023 | - | $54.22 M(-479.5%) | $144.51 M(+7.0%) |
| June 2023 | - | -$14.29 M(-113.8%) | $135.07 M(-19.0%) |
| Mar 2023 | - | $103.48 M(+9367.7%) | $166.66 M(+87.0%) |
| Dec 2022 | $89.12 M(-120.9%) | $1.09 M(-97.6%) | $89.12 M(+137.9%) |
| Sept 2022 | - | $44.78 M(+158.8%) | $37.46 M(-128.9%) |
| June 2022 | - | $17.30 M(-33.3%) | -$129.48 M(-36.6%) |
| Mar 2022 | - | $25.93 M(-151.3%) | -$204.32 M(-52.1%) |
| Dec 2021 | -$426.97 M(-194.4%) | -$50.57 M(-58.6%) | -$426.97 M(+83.5%) |
| Sept 2021 | - | -$122.15 M(+112.3%) | -$232.64 M(+1900.5%) |
| June 2021 | - | -$57.53 M(-70.8%) | -$11.63 M(-105.8%) |
| Mar 2021 | - | -$196.72 M(-236.8%) | $199.76 M(-55.9%) |
| Dec 2020 | $452.49 M(+277.0%) | $143.77 M(+45.4%) | $452.49 M(+59.5%) |
| Sept 2020 | - | $98.86 M(-35.7%) | $283.69 M(-16.0%) |
| June 2020 | - | $153.85 M(+174.7%) | $337.60 M(+66.7%) |
| Mar 2020 | - | $56.01 M(-323.7%) | $202.51 M(+68.7%) |
| Dec 2019 | $120.02 M | -$25.03 M(-116.4%) | $120.02 M(-137.8%) |
| Sept 2019 | - | $152.77 M(+713.9%) | -$317.81 M(-43.2%) |
| June 2019 | - | $18.77 M(-170.9%) | -$559.78 M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$26.49 M(-94.3%) | -$563.91 M(+8.0%) |
| Dec 2018 | -$522.12 M(-847.3%) | -$462.86 M(+418.9%) | -$522.12 M(+1229.6%) |
| Sept 2018 | - | -$89.20 M(-709.4%) | -$39.27 M(-166.0%) |
| June 2018 | - | $14.64 M(-4.3%) | $59.48 M(-3.7%) |
| Mar 2018 | - | $15.30 M(-23.5%) | $61.76 M(-11.6%) |
| Dec 2017 | $69.87 M(+955.1%) | $20.00 M(+109.6%) | $69.87 M(+71.4%) |
| Sept 2017 | - | $9.54 M(-43.6%) | $40.75 M(+2.4%) |
| June 2017 | - | $16.92 M(-27.7%) | $39.80 M(+59.4%) |
| Mar 2017 | - | $23.41 M(-356.8%) | $24.97 M(+277.1%) |
| Dec 2016 | $6.62 M(-212.8%) | -$9.12 M(-206.2%) | $6.62 M(+64.3%) |
| Sept 2016 | - | $8.59 M(+310.2%) | $4.03 M(-184.6%) |
| June 2016 | - | $2.09 M(-58.6%) | -$4.76 M(-11.2%) |
| Mar 2016 | - | $5.06 M(-143.2%) | -$5.36 M(-8.6%) |
| Dec 2015 | -$5.87 M(-94.5%) | -$11.71 M(+5527.9%) | -$5.87 M(-95.6%) |
| Sept 2015 | - | -$208.00 K(-113.9%) | -$134.46 M(+2.8%) |
| June 2015 | - | $1.49 M(-67.2%) | -$130.84 M(+13.8%) |
| Mar 2015 | - | $4.55 M(-103.2%) | -$114.95 M(+7.1%) |
| Dec 2014 | -$107.29 M(-1095.4%) | -$140.29 M(-4214.2%) | -$107.29 M(-425.1%) |
| Sept 2014 | - | $3.41 M(-80.4%) | $33.00 M(+11.5%) |
| June 2014 | - | $17.38 M(+42.3%) | $29.59 M(+142.3%) |
| Mar 2014 | - | $12.21 M | $12.21 M |
| Dec 2013 | $10.78 M(-43.7%) | - | - |
| Dec 2012 | $19.15 M | - | - |
FAQ
- What is FibroGen annual cash flow from investing activities?
- What is the all time high annual CFI for FibroGen?
- What is FibroGen annual CFI year-on-year change?
- What is FibroGen quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for FibroGen?
- What is FibroGen quarterly CFI year-on-year change?
- What is FibroGen TTM cash flow from investing activities?
- What is the all time high TTM CFI for FibroGen?
- What is FibroGen TTM CFI year-on-year change?
What is FibroGen annual cash flow from investing activities?
The current annual CFI of FGEN is $153.66 M
What is the all time high annual CFI for FibroGen?
FibroGen all-time high annual cash flow from investing activities is $452.49 M
What is FibroGen annual CFI year-on-year change?
Over the past year, FGEN annual cash flow from investing activities has changed by +$64.54 M (+72.42%)
What is FibroGen quarterly cash flow from investing activities?
The current quarterly CFI of FGEN is $755.00 K
What is the all time high quarterly CFI for FibroGen?
FibroGen all-time high quarterly cash flow from investing activities is $153.85 M
What is FibroGen quarterly CFI year-on-year change?
Over the past year, FGEN quarterly cash flow from investing activities has changed by -$53.46 M (-98.61%)
What is FibroGen TTM cash flow from investing activities?
The current TTM CFI of FGEN is $134.51 M
What is the all time high TTM CFI for FibroGen?
FibroGen all-time high TTM cash flow from investing activities is $452.49 M
What is FibroGen TTM CFI year-on-year change?
Over the past year, FGEN TTM cash flow from investing activities has changed by -$10.00 M (-6.92%)